Clinuvel Pharmaceuticals (CLVLY) DIvidends Date & History

Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria... Show more

Get AI intraday signals

A.I.Advisor

published Dividends

CLVLY is expected to pay dividends on September 29, 2025

Clinuvel Pharmaceuticals CLVLY Stock Dividends

A dividend of $0.03 per share will be paid with a record date of September 29, 2025, and an ex-dividend date of September 08, 2025. The last dividend of $0.03 was paid on September 30. Read more...

View a ticker or compare two or three

Compare

CLVLY

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CLVLY
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

535 Bourke Street

Phone

+61 396604900

Employees

Web

https://www.clinuvel.com